|NCTC Number:||NCTC 10315|
|Current Name:||Bacillus subtilis|
|Original Strain Reference:||MB 32|
|Other Collection No:||MB 32; NCIB 8993|
|Previous Catalogue Name:||Bacillus subtilis|
|Hazard Group (ACDP):||2|
|Release Restrictions:||Terms & Conditions of Supply of Microbial Pathogens: Safety|
|Conditions for growth on solid media:||nutrient agar,37, aerobic|
|Conditions for growth on liquid media:||nutrient broth,37, aerobic|
|Data:||(NCIB 8993) NCIB in 1962 / Glaxo Laboratories Ltd / Assay of novobiocin / British Pharmacopoeia 1973, p. A104|
|History:||GLAXO LABORATORIES LTD|
|Authority:||(Ehrenberg 1835) Cohn 1872 (AL)|
|Taxonomy:||TaxLink: S436 (Bacillus subtilis subsp. subtilis (Ehrenberg 1835) Cohn 1872) - Date of change: 5/02/2003|
|Other:||ANTIBIOTIC (AND OTHER ANTIMICROBIALS) ASSAY, SENSITIVITY, RESISTANCE CONTROL STRAINS Novobiocin|
|Biosafety Responsibility:||It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country|
The Culture Collections hold cell cultures, bacteria, fungi and virus strains from worldwide sources. Our scientists ensure that the identification of the cultures is correct and they remain unchanged from when they are first deposited with the Collection. Nevertheless, some of the data we provide about the cultures is supplied by the person depositing the strains and, although we have multiple checking procedures in place, we cannot always verify all their data. Please note that the Culture Collections cannot be held responsible for any inaccuracies in the data provided by the depositors.
Cultures supplied by Culture Collections are to be used as controls for microbiology testing and for research purposes only. Please view the Terms & Conditions of Supply for more information.
Contact us if you want to discuss commercial use of the cultures.
Please confirm your country of origin from the list below.